Bahl & Gaynor
SNV icon

Bahl & Gaynor’s Synovus SNV Stock Holding History

Bahl & Gaynor’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,622
Closed -$432K – 336
2025
Q4 		$432K Hold
8,622
– – ﹤0.01% 294
2025
Q3 		$423K Hold
8,622
– – ﹤0.01% 292
2025
Q2 		$446K Hold
8,622
– – ﹤0.01% 290
2025
Q1 		$403K Hold
8,622
– – ﹤0.01% 299
2024
Q4 		$442K Hold
8,622
– – ﹤0.01% 291
2024
Q3 		$383K Buy
8,622
+1,748
+25% +$76.4K ﹤0.01% 303
2024
Q2 		$276K Hold
6,874
– – ﹤0.01% 309
2024
Q1 		$275K Hold
6,874
– – ﹤0.01% 312
2023
Q4 		$259K Buy
+6,874
New +$210K ﹤0.01% 314
2023
Q3 		– Sell
-6,874
Closed -$208K – 345
2023
Q2 		$208K Hold
6,874
– – ﹤0.01% 333
2023
Q1 		$212K Hold
6,874
– – ﹤0.01% 328
2022
Q4 		$258K Buy
+6,874
New +$273K ﹤0.01% 313

Other funds holding SNV

WBWA
William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Bahl & Gaynor's SNV Position: Q1 2026 in Review

Bahl & Gaynor sold out of Synovus (SNV) in Q1 2026, closing a stake of 8,622 shares — an estimated $432K sold.

Bahl & Gaynor first reported a position in SNV in Q4 2022 and held it in 12 quarters. The position peaked at $446K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Bahl & Gaynor reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Bahl & Gaynor sold 8,622 Synovus shares in Q1 2026, an estimated $432K.
  • Bahl & Gaynor first reported a position in Synovus in Q4 2022 and held it in 12 quarters.
  • Bahl & Gaynor's Synovus position peaked at $446K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.